[1] Oertel W, Schulz JB.Current and experimental treatments of parkinson disease: A guide for neuroscientists[J]. Journal of Neurochemistry, 2016, 139(Suppl 1): 325-337. [2] Heiko B, Kelly DT, Udo R, et al.Staging of brain pathology related to sporadic parkinson's disease[J]. Neurobiology of Aging, 2003, 24(2): 197-211. [3] Heiko B, Rob AIV, Jürgen B, et al.Gastric α-synuclein immunoreactive inclusions in meissner's and auerbach's plexuses in cases staged for parkinson's disease-related brain pathology[J]. Neuroscience Letters, 2006, 396(1): 67-72. [4] Derkinderen P, Rouaud T, Lebouvier T, et al.Parkinson disease: the enteric nervous system spills its guts[J]. Neurology, 2011, 77( 19): 1761-1767. [5] Mittal R, Debs LH, Patel AP, et al.Neurotransmitters: the critical modulators regulating gut-brain axis[J]. Journal of Cellular Physiology, 2017, 232(9): 2359-2372. [6] Jackson-Lewis V, Przedborski S.Protocol for the MPTP mouse model of parkinson's disease[J]. Nature Protocols, 2007, 2(1): 141-151. [7] Lydén-Sokolowski A, Larsson BS, Lindquist NG.Disposition of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition[J]. Pharmacology & Toxicology, 1988, 63(2): 75-80. [8] Vanderlei de AL, Lucas AN, David E, et al. Role of parkinson's disease-linked mutations and N-terminal acetylation on the oligomerization of α-synuclein induced by DOPAL[J]. ACS Chemical Neuroscience, 2019, 10(1): 690-703. [9] Tache Y, Martinez V, Million M, et al.Stress and the gastrointestinal tract iii. stress-related alterations of gut motor function[J]. American Journal of Physiology, 2001, 280(2): G173-G177. [10] Natale G, Pasquali L, Ruggieri S, et al.Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation[J]. Neurogastroenterology & Motility, 2010, 20(7): 741-749. [11] Gulbransen BD, Sharkey KA.Novel functional roles for enteric glia in the gastrointestinal tract[J]. Nature Reviews Gastroenterology & Hepatology, 2012, 9(11): 625-32. [12] Clairembault T, Kamphuis W, Leclair-Visonneau L, et al.Enteric GFAP expression and phosphorylation in parkinson's disease[J]. Journal of Neurochemistry, 2014, 130(6): 805-815. [13] CorbilléAG, Clairembault T, Coron E, et al. What a gastroin-testinal biopsy can tell us about Parkinson's disease?[J]. Neuro- gastroenterology & Motility, 2016, 28(7): 966-974. [14] Dinan TG, Cryan JF.The microbiome-gut-brain axis in health and disease[J]. Gastroenterology Clinics of North America, 2017, 46(1): 77-89. [15] Valentina C, Maria G.Microbiome-gut-brain axis and toll-like receptors in parkinson's disease[J]. International Journal of Molecular Sciences, 2018, 19(6): 1689. |